Debabrata Bandyopadhyay
Overview
Explore the profile of Debabrata Bandyopadhyay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
172
Citations
642
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tourki B, Jia M, Karampitsakos T, Vera I, Arsenault A, Fatima Z, et al.
Am J Physiol Cell Physiol
. 2024 Nov;
328(1):C199-C211.
PMID: 39510135
We aimed to study transcriptional and phenotypic changes in circulating immune cells associated with increased risk of mortality in COVID-19, resolution of pulmonary fibrosis in post-COVID-19-interstitial lung disease (ILD), and...
2.
The transcriptome of CD14 CD163 HLA-DR monocytes predicts mortality in Idiopathic Pulmonary Fibrosis
Karampitsakos T, Tourki B, Jia M, Perrot C, Visinescu B, Zhao A, et al.
medRxiv
. 2024 Aug;
PMID: 39211854
Rationale: The association between immune-cell-specific transcriptomic profiles and Idiopathic Pulmonary Fibrosis (IPF) mortality is unknown. Objectives: To determine immune-cell-specific transcriptomic profiles associated with IPF mortality. Methods: We profiled peripheral blood...
3.
Nathan S, Rajicic N, Dudenhofer R, Hussain R, Argula R, Bandyopadhyay D, et al.
Ann Am Thorac Soc
. 2024 Aug;
21(12):1661-1669.
PMID: 39141673
Inhaled nitric oxide (iNO) has been shown to result in benefits in moderate to vigorous physical activity (MVPA) in patients with fibrotic interstitial lung disease (f-ILD) receiving supplemental oxygen in...
4.
Arslan A, Smith J, Qureshi M, Uysal A, Patel K, Herazo-Maya J, et al.
Front Med (Lausanne)
. 2024 Feb;
10:1306032.
PMID: 38298504
Interstitial lung diseases (ILD) are a spectrum of disorders often complicated by pulmonary hypertension (PH) in its course. The pathophysiologic mechanism of WHO group 3 PH is different to other...
5.
Perrot C, Karampitsakos T, Unterman A, Adams T, Marlin K, Arsenault A, et al.
Am J Physiol Cell Physiol
. 2024 Jan;
326(3):C964-C977.
PMID: 38189137
Mast-cell expressed membrane protein-1 (MCEMP1) is higher in patients with idiopathic pulmonary fibrosis (IPF) with an increased risk of death. Here we aimed to establish the mechanistic role of MCEMP1...
6.
Zadeh A, Dinparastisaleh R, Vaezi A, Bandyopadhyay D, Rubinstein I, Baig H, et al.
Ann Am Thorac Soc
. 2023 Dec;
21(3):428-437.
PMID: 38134434
Hospital readmission within 30 days poses challenges for healthcare providers, policymakers, and patients because of its impact on care quality, costs, and outcomes. Patients with interstitial lung disease (ILD) are...
7.
Perrot C, Karampitsakos T, Unterman A, Adams T, Marlin K, Arsenault A, et al.
bioRxiv
. 2023 Oct;
PMID: 37873485
Background: Mast-Cell Expressed Membrane Protein-1 (MCEMP1) is higher in Idiopathic Pulmonary Fibrosis (IPF) patients with increased risk of death and poor outcomes. Here we seek to establish the mechanistic role...
8.
Bandyopadhyay D, Mirsaeidi M
Eur Respir Rev
. 2023 Sep;
32(169).
PMID: 37758275
Sarcoidosis is a multisystem granulomatous disorder of unknown aetiology. A minority of patients with sarcoidosis develop sarcoidosis-associated pulmonary fibrosis (SAPF), which may become progressive. Genetic profiles differ between patients with...
9.
Das A, Sil A, Khan I, Bandyopadhyay D
Clin Exp Dermatol
. 2023 Feb;
48(6):599-608.
PMID: 36806485
Tyrosine kinase inhibitors (TKIs) target the signal transduction pathways of protein kinases by several modes of inhibition. Adverse effects are generally dose dependent, with certain side-effects unique to each drug....
10.
Lal N, Basu D, Saha A, Ghosh R, Verma R, Bandyopadhyay D
Indian J Dermatol Venereol Leprol
. 2023 Jan;
89(5):665-671.
PMID: 36688883
Background Though higher doses of terbinafine are often prescribed to treat dermatophyte infections, it is unknown if such doses are more effective than the conventional dose because comparative data are...